Memantine Hydrochloride Tablets

Jump to

Ajanta Pharma shares up 2% on launch of anti-dementia drug in US

United States Food & Drug Administration has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its abbreviated new drug application, it said, adding another 14 ANDAs are pending approval from the USFDA.
Aurobindo gets USFDA nod for Alzheimer's treatment drug

"The company has received the final approval from the US Food & Drug Administration (US FDA) to manufacture and market Memantine Hydrochloride Tablets, 5mg and 10mg (ANDA 203175)," Aurobindo Pharma said in a BSE filing.
Jubilant Life up 3.5% on USFDA nod for anti-dementia drug

"Jubilant Life has received abbreviated new drug application (ANDA) final approval from the USFDA for Memantine hydrochloride tablets USP, 5 mg and 10 mg," the pharmaceuticals and life sciences company said in its filing.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Memantine Hydrochloride Tablets

Ajanta Pharma shares up 2% on launch of anti-dementia drug in US

Aurobindo gets USFDA nod for Alzheimer's treatment drug

Jubilant Life up 3.5% on USFDA nod for anti-dementia drug